The Latest
-
Rite Aid Asks Bondholders for More Time Amid Tepid Turnaround
-
Covid-Linked Stocks Rally on Trump’s ‘Surprise’ Hint, Day Trades
-
Another 1.48M Americans filed for unemployment benefits
-
The Daily Biotech Pulse: Merck’s Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy